hypoparathyroidism


Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Related to hypoparathyroidism: hyperparathyroidism, pseudohypoparathyroidism
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Antonyms for hypoparathyroidism

inadequate secretion of parathyroid hormone resulting in abnormally low levels of calcium in the blood

References in periodicals archive ?
If there was still hypoparathyroidism and hypocalcemia after drug withdrawal, it was permanent hypoparathyroidism.
Shire plc (LSE:SHP)(Nasdaq:SHPG) reported on Tuesday that it has received Conditional Marketing Authorisation for Natpar (rhPTH[1-84]) from the European Commission (EC) for the treatment of chronic hypoparathyroidism.
Besides calcium metabolism disorder, hypoparathyroidism or pseudo hypoparathyroidism, various factors caused by genetic, developmental, metabolic, infectious, sporadic, anoxic and other conditions have been reported.
Additionally, the report provides an overview of key players involved in therapeutic development for Hypoparathyroidism and features dormant and discontinued projects.
European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults.
Hypoparathyroidism is reported to affect 3% to 7 % of patients and is attributed to iron deposition in the parathyroid.
Many studies have been done on endocrine disorders including hypoparathyroidism in thalassemia patients and frequency reported varies from centre to centre but largest study so far done included 1861 patients from 25 centres and showed that 3.
Natpara (parathyroid hormone) for injection is indicated as an adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism.
People with hypoparathyroidism have limited treatment options and face challenging symptoms that can severely impact their quality of life.
Her serum calcium levels remained normal on this regimen after hospital discharge despite persistent hypoparathyroidism.
Hypoparathyroidism is a rare endocrine disorder characterized by insufficient levels of parathyroid hormone, or PTH.
Another drug, Natpara, treats a hormone condition called hypoparathyroidism and could be a major money maker if approved by the FDA.
Shire gains two new drugs, Gattex, a treatment for short-bowel syndrome (SBS), and Natpara, which is awaiting approval from the FDA for hypoparathyroidism.